Vous êtes sur la page 1sur 6

Wells Fargo Securities Research, Economics & Strategy

2016 Healthcare Conference |Participating Companies


September 7-8, 2016 | The Westin Waterfront | Boston, MA

Company

Attendees

Abbott Laboratories (ABT)

Brian Yoor, SVP, Finance & CFO; Mike Comilla; Senior


Director, IR; Elizabeth Corbin, Sr. Manager IR

Acadia Healthcare Company, Inc. (ACHC)

Brent Turner, President

Advisory Board Company (ABCO)

Robert Musslewhite, Chairman & CEO; Michael Kirshbaum,


CFO; Robert Borchert, VP, IR

Aeglea Biotherapeutics, Inc. (AGLE)

David Lowe, President & CEO; Charles York, CFO; Sandra


Rojas-Caro, Chief Medical Officer

Affimed N.V. (AFMD)

Adi Hoess, CEO; Caroline Stewart, IR Representative

Alder Biopharmaceuticals, Inc. (ALDR)

Randall Schatzman, President & CEO; Mark Litton, CBO;


David Walsey, VP, Corporate Communications

Allergan plc (AGN)

Brent Saunders, CEO & President; Sanjiv Patel, EVP, Chief


Strategy Officer; Lisa Defrancesco, VP, IR; David
Nicholson, Head of Brand R&D; Karina Calzadilla,ED, IR

Allscripts Healthcare Solutions, Inc. (MDRX)

Rick Poulton, President; Seth Frank, VP, Finance

Amedisys Inc (AMED)

Paul Kusserow, President & CEO; Ronnie LaBorde, Vice


Chairman & CFO; David Castille, Managing Director,
Finance

American Renal Associates Holdings, Inc. (ARA)

Jon Wilcox, CFO;Darren Lehrich, SVP, Strategy & IR

Amphastar Pharmaceuticals, Inc. (AMPH)

Jason Shandell, President; Bill Peters, CFO

Array BioPharma Inc. (ARRY)

Ron Squarer, CEO; Jason Haddock, CFO; Victor Sandor,


Chief Medical Officer

AstraZeneca PLC (AZN-GB)

Mitchell Chan, Director, IR; Lindsey Trickett, IR Director

Benefitfocus Inc (BNFT)

Michael Bauer, Head of IR

bluebird bio, Inc. (BLUE)

Dave Davidson, Chief Medical Officer; Nick Leschly, Chief


bluebird; Manisha Pai, Head of IR

Boston Scientific Corporation (BSX)

Dan Brennan, EVP & CFO; Susie Lisa, VP, IR

Brookdale Senior Living, Inc. (BKD)

Andy Smith, President & CEO; Cindy Baier, CFO; Ross


Roadman, SVP, IR

Brooks Automation, Inc. (BRKS)

Lindon Robertson, CFO; Dusty Tenney, President, Life


Sciences Division

Wells Fargo Securities is the trade name for the capital markets and investment banking
services of Wells Fargo & Company and its subsidiaries, including but not limited to Wells
Fargo Securities, LLC, a U.S. broker dealer registered with the U.S. Securities and Exchange
Commission and a member of NYSE, FINRA, NFA and SIPC, Wells Fargo Institutional
Securities, LLC, a member of FINRA and SIPC, Wells Fargo Prime Services, LLC, a member
of FINRA, NFA and SIPC, Wells Fargo Bank, N.A. and Wells Fargo Securities International
Limited, authorized and regulated by the Financial Conduct Authority.
2016 Wells Fargo Securities. All rights reserved.

Company

Attendees

Bruker Corporation (BRKR)

Frank Laukien, President & CEO; Tony Mattacchione, CFO;


Stacey Desrochers, Treasurer & Interim Director of IR

Calithera Biosciences, Inc. (CALA)

Susan Molineaux, CEO; Will Waddill, CFO; Jennifer


McNealey, IR

Cambrex Corporation (CBM)

Greg Sargen, EVP & CFO; Hannah Deresiewicz, IR


Associate

Capital Senior Living (CSU)

Larry Cohen, CEO; Carey Hendrickson, SVP, CFO

Centene Corporation (CNC)

Erica Silver, Sr. Manage, Financial Analysis; Ed Kroll, SVP,


Finance & IR

Cerner Corporation (CERN)

Marc Naughton, EVP & CFO; Allan Kells, VP, IR

Charles River Laboratories International, Inc. (CRL)

David Smith, EVP & CFO; Todd Spencer, Senior Director,


IR

Community Health Systems Inc. (CYH)

Larry Cash, President, Financial Services, & CFO; Kevin


Hammons, SVP & Chief Accounting Officer; Ross
Comeaux, Director of IR

Computer Programs & Systems, Inc. (CPSI)

Boyd Douglas, President & CEO

Concert Pharmaceuticals Inc. (CNCE)

Roger Tung, Ph.D., President & CEO; Ryan Daws, CFO;


Nancy Stuart COO; Justine Koenigsberg, VP, IR

ConforMIS, Inc. (CFMS)

Philipp Lang, CEO and President; Paul Weiner, CFO; Enzo


LiCausi, Corporate Controller; Oksana Bradley, IR Manager

Cooper Companies, Inc. (COO)

Al White, EVP & Chief Strategy Officer; Kim Duncan, VP,


IR

CVS Health Corporation (CVS)

Eva Boratto, SVP and Controller; Nancy Christal, SVP, IR;


Mike McGuire, VP, IR

Dimension Therapeutics Inc. (DMTX)

Annalisa Jenkins, CEO; Jean Franchi, CFO; Deborah


Geraghty, VP

Diplomat Pharmacy, Inc. (DPLO)

Phil Hagerman, CEO; Sean Whelan, CFO

Edwards Lifesciences Corporation (EW)

Michael Mussallem, Chairman & CEO; David Erickson, VP,


IR

Fate Therapeutics, Inc. (FATE)

Scott Wolchko, President & CEO; Dan Shoemaker, Chief


Scientific Officer

Flexion Therapeutics, Inc. (FLXN)

Michael Clayman, CEO; Daniel Deardorf, SVP,


Commercial; Christina Willwerth, SVP, Program
Management

Forward Pharma (FWP)

Joel Sendek, CFO

Genomic Health, Inc. (GHDX)

Kim Popovits, President & CEO; Phil Febbo, Chief Medical


Officer; Brian Hogan, VP of Finance; Emily Faucette, VP,
Corp. Communications & IR

Gilead Sciences, Inc. (GILD)

Kevin Young CBE, Chief Operating Officer; Norbert


Bischofberger PhD, EVP, Research & Development & Chief
Scientific Officer

GlaxoSmithKline plc Sponsored ADR (GSK)

Jeff McLaughlin, Director, Investor Relations

2016 Healthcare Conference | Presenting Companies

Page 2 of 6

Company

Attendees

Global Blood Therapeutics Inc (GBT)

Ted W. Love, M.D.; President and CEO; Jeff Farrow, CFO;


Myesha Edwards, IR & Corporate Communications; Ken
Bridges, VP, Medical Affairs

Globus Medical, Inc. (GMED)

Dan Scavilla, SVP & CFO; Brian Kearns, VP, IR

Halozyme Therapeutics, Inc. (HALO)

Helen Torley, CEO; Athena Countouriotis, CMO; Chris


Burton, Director, IR

Healthequity, Inc (HQY)

Jon Kessler, CEO; Darcy Mott, CFO; Richard Putnam,


Director of IR

HealthSouth Corporation (HLS)

Doug Coltharp, EVP & CFO; Mark Tarr, EVP & COO; Crissy
Carlisle, Chief IR Officer; Lisa Charbonneau, Chief Medical
Officer

Hill-Rom Holdings, Inc. (HRC)

Steve Strobel, CFO; Mary Kay Ladone, VP, IR

HMS Holdings Corp (HMSY)

Jeff Sherman, EVP, CFO & Treasurer; Dennis Oakes, SVP,


IR

Humana Inc. (HUM)

Bruce Broussard, President & CEO; Brian Kane, SVP &


CFO; Regina Nethery, Enterprise Vice President, IR

IASIS Healthcare LLC (Private)

John Doyle, CFO; Eric Descher, VP, Financial Reporting

ICON plc (ICLR)

Brendan Brennan, CFO; Steve Cutler, COO

Immune Design Corp. (IMDZ)

Carlos Paya, President & CEO; Stephen Brady, EVP,


Strategy & Finance; Shari Annes, IR

Immunomedics, Inc. (IMMU)

Cynthia Sullivan, President & CEO; Michael Garone, VP,


Finance & CFO; Chau Cheng, Sr. Director, IR & Corporate
Secretary

INC Research Holdings, Inc. (INCR)

Greg Rush, CFO; Ronnie Speight, VP, IR

Innoviva Inc (INVA)

Mike Aguiar, President & CEO; Mike Faerm, SVP & CBO;
Eric dEsparbe, SVP & CFO

Integra Lifesciences Holdings Corp (IART)

Glenn Coleman, CFO; Angela Steinway, Global Head of IR


& Strategic Initiatives; Jeff Mosebrook, VP, Corporate
Controller

Intellia Therapeutics Inc (NTLA)

Nessan Bermingham, CEO, President & Founder; Sapna


Srivastava, Chief Finance & Strategy Officer; John
Graziano, IR Representative

Ionis Pharmaceuticals, Inc. (IONS)

Sarah Boyce, CBO; D. Wade Walke, VP, Corp.


Communications & IR; Paula Soteropoulos, CEO of Akcea
Therapeutics

Ironwood Pharmaceuticals, Inc. Class A (IRWD)

Tom Graney, CFO; Meredith Kaya, Director, IR

Jazz Pharmaceuticals Plc (JAZZ)

Karen Smith; Global Head of R&D and CMO; Mike Miller,


SVP, US Commercial; Kathee Littrell, VP, IR

Johnson & Johnson (JNJ)

Dominic Caruso, EVP, CFO; Joe Wolk, VP, Finance; Lisa


Romanko, Sr. Director, IR

K2M Group Holdings Inc (KTWO)

Greg Cole, CFO; Michael Piccinino, IR

2016 Healthcare Conference | Presenting Companies

Page 3 of 6

Company

Attendees

Landauer, Inc. (LDR)

Mike Kaminski, President & CEO; Dan Fujii, CFO

Lantheus Holdings, Inc. (LNTH)

Mary Anne Heino, President & CEO; Jack Crowley, CFO;


Meara Murphy, Director, IR & Corp. Communications

LHC Group, Inc. (LHCG)

Keith Myers, CEO; Eric Elliott, SVP of Finance

LifePoint Health Inc. (LPNT)

William Carpenter, EVP, CEO; Michael Coggin, Chief


Accounting Officer; Dvid Dill, EVP & COO

Mallinckrodt Plc (MNK)n

Mark Trudeau, President & CEO; Dr. Steven Romano, SVP,


Chief Science Officer; Cole Lannum, SVP, Investor
Strategy & IRO; Daniel Speciale, Director of IR

MAXIMUS, Inc. (MMS)

Bruce Caswell, President; Lisa Miles, SVP Corporate


Communications & IR

MediWound Ltd. (MDWD)

Gal Cohen, President & CEO; Sharon Malka, CFO; Ann


Marie Fields, SVP, IR

Medpace Holdings, Inc. (MEDP)

August J. Troendle, MD, President & CEO; Jesse J. Greiger,


CPA, CFO & COO, Laboratory Operations

Medtronic plc (MDT)

Geoff Martha, EVP & President, Restorative Therapies


Group; Andy Stone, Manager, IR

Merck & Co., Inc. (MRK)

Roger Dansey, SVP, Clinical Research; Teri Loxam, VP, IR

Merit Medical Systems, Inc. (MMSI)

Fred Lampropoulos, Chairman & CEO

Momenta Pharmaceuticals, Inc. (MNTA)A

Rick Shea, CFO; Sarah Carmody, Director, IR & Corporate


Communications

MyoKardia Inc. (MYOK)

Tassos Gianakakos, CEO; Jake Bauer, SVP, Finance &


Corporate Development; Jonathan Fox, M.D., Ph.D., Chief
Medical Officer

Neos Therapeutics, Inc. (NEOS)

Vipin Garg, President & CEO; Richard Eisenstadt, CFO

Nevro Corp. (NVRO)

Andrew Galligan, CFO; Monica Prokocki, Sr. Mgr,


Corporate Development & IR; Katherine Bock, Sr.
Director, Corporate Development & IR

Novartis AG Sponsored ADR (NVS)

Richard Pulik, VP, NA, Head of IR; Sloan Pavsner, IR


Officer

NovoCure Limited (NVCR)

William Doyle, Executive Chairman; Ashley Cordova, Vice


President of Finance and Investor Relations; Stephanie
Zhadkevich, IR Manager

NuVasive, Inc (NUVA)

Quentin Blackford, EVP & CFO; Carol Cox, EVP, External


Affairs & Corporate Marketing

Omnicell, Inc. (OMCL)

Peter Kuipers, EVP, CFO; Michelle Smith, VP of Finance &


Corporate Treasurer; Joe Colone, IR/Treasury Analyst

OncoMed Pharmaceuticals, Inc. (OMED)

Paul J. Hastings, Chairman & CEO; Jakob Dupont, Chief


Medical Officer; Michelle Corral, Senior Director, IR

OPKO Health, Inc. (OPK)

Phillip Frost, MD, Chairman of the Board & CEO; Steve D.


Rubin, EVP, Administration; Adam Logal, SVP & CFO; Dave
Okrongly, President, OPKO Diagnostics

2016 Healthcare Conference | Presenting Companies

Page 4 of 6

Company

Attendees

PAREXEL International Corporation (PRXL)

Josef von Rickenbach, Chairmen & CEO; Ron Aldridge, Sr.


Director, IR

Penumbra, Inc. (PEN)

Adam Elsesser, CEO; Sri Kosaraju, CFO & Head of


Strategy; Dan Wilson, Director & Head of Business
Development

Pfizer, Inc. (PFE)

Ian Read, Chairman & CEO; Navin Katyal, VP, Operations,


Office of the CEO; Chuck Triano, SVP, IR

Premier, Inc. (PINC)

Susan DeVore, CEO; Craig McKasson, CFO; Jim Storey,


VP, IR

Quidel Corporation (QDEL)

Doug Bryant, President & CEO; Randy Steward, CFO;


Ruben Argueta, Director of IR

Regulus Therapeutics Inc (RGLS)

Paul Grint, CEO; Jay Hagan, COO; Allison Wey, VP, IR &
Corp. Communications

Revance Therapeutics, Inc. (RVNC)

Dan Browne, President & CEO; Lauren Silvernail, CFO &


Chief Business Officer; Jeanie Herbert, Senior Director, IR
& Corporate Communications

Sangamo Biosciences Inc. (SGMO)

Sandy Macrae, President & CEO; Ward Wolff, EVP & CFO;
Liz Wolffe, VP, Corporate Communications and IR

Select Medical Holdings Corporation (SEM)

Bob Ortenzio, Executive Chairman; Marty Jackson, EVP &


CFO

Service Corp. International (SCI)

Eric Tanzberger, SVP, CFO & Treasurer; Melissa Tompkins,


MD, Financial Planning & Analysis; Aaron Foley, MD,
Treasury / Assistant Treasurer

Shire PLC Sponsored ADR (SHPG)

Mark Rus, VP Product Management, Neurosciences and


Commercial Excellence; Ian Karp, Head of U.S. Investor
Relations

Stryker Corporation (SYK)

Katherine Owen, VP, Strategy & IR

Sunesis Pharmaceuticals, Inc. (SNSS)

Eric Bjerkholt, EVP, Corporate Development & Finance,


CFO

TeamHealth Holdings, Inc. (TMH)

David Jones, EVP & CFO; James Bierman, Lead Director

Teladoc, Inc. (TDOC)

Jason Gorevic, CEO; Mark Hirschhorn, CFO

Tesaro, Inc. (TSRO)

Mary Lynne Hedley, President & COO; Lonnie Moulder,


CEO; Kate Rausch, Associate Director, IR

Teva Pharmaceutical Industries Limited Sponsored ADR


(TEVA)

Eyal Desheh, Group EVP & CFO; Ran Meir, VP, IR

The Ensign Group, Inc (ENSG)

Chad Keetch, EVP; CFO; Barry Port, COO

Thermo Fisher Scientific Inc. (TMO)

Rafael Tejada, Senior Director, IR; Ken Apicerno, VP, IR

TRACON Pharmaceuticals, Inc. (TCON)

Charles Theuer, President & CEO; Patricia Bitar, CFO

2016 Healthcare Conference | Presenting Companies

Page 5 of 6

Company

Attendees

Triple-S Management Corporation (GTS)

Roberto Garcia-Rodriguez, President & CEO; Juan Jose


Roman-Jimenez, EVP & CFO; Kathy Walker, IR

UnitedHealth Group (UNH)

Dave Wichmann, President; John Penshorn, SVP; Austin


Pittman, CEO UnitedHealthcare, Community & State

Universal Health Servics, Inc. (UHS)

Steve Filton, CFO

Valeant Pharmaceuticals Intl Inc (VRX)

Joseph Papa, Chairman & CEO; Scott Hirsch, SVP,


Strategy & Communications

Vitae Pharmaceuticals, Inc. (VTAE)

Jeff Hatfield, President & CEO; Rich Morris, CFO

Vocera Communications, Inc. (VCRA)

Justin Spencer, EVP & CFO; Sue Dooley, IR

VolitionRX Ltd (VNRX)

Cameron Reynolds, CEO; David Kratochvil, CFO; Scott


Powell, VP, IR

Voyager Therapeutics, Inc. (VYGR)

Steven Paul, MD, CEO; Jeff Goater, CFO; Matt Osborne, IR

VWR Corp. (VWR)

Greg Cowan, CFO; John Sweeney, VP, IR

Waters Corporation (WAT)

Gene Cassis, CFO; Terry Kelly, President, TA Instruments


Division; John Lynch, VP, Treasurer & IR

WellCare Health Plans, Inc. (WCG)

Drew Asher, CFO; Angie McCabe, VP, IR

West Pharmaceutical Services, Inc. (WST)

Eric Green, CEO; William Federici, CFO; Quintin Lai, VP


Corporate Development, Strategy & IR

Wright Medical Group N.V. (WMGI)

Bob Palmisano, President & CEO; Julie Tracy, SVP, Chief


Communications Officer

Xenon Pharmaceuticals Inc. (XENE)

Simon Pimstone, President and CEO; Ian Mortimer, CFO &


COO; Jodi Regts, Sr. Director, Corporate Affairs / IR

Zimmer Biomet Holdings Inc (ZBH)

Bob Marshall, VP, IR & Treasurer

ZIOPHARM Oncology, Inc. (ZIOP

Laurence Cooper, MD, CEO; Francois Lebel, MD, CMO;


Melissa Forst, IR

2016 Healthcare Conference | Presenting Companies

Page 6 of 6